"Company (date of emergency use authorisaztion, test name)",1-day share price move
"GenMark Diagnostics (19 March, ePlex Sars-CoV-2 Test)",41%
"Quidel (17 March, Lyra Sars-CoV-2 assay)",26%
"Roche Molecular Systems (13 March, Cobas Sars-CoV-2 test)",13%
"Diasorin Molecular (19 March, Simplexa Covid-19 Direct assay)",8%
"Thermo Fisher Scientific (13 March, TaqPath Covid-19 Combo Kit)",5%
"Labcorp (16 March, Covid-19 RT-PCR test)",2%
"Hologic (16 March, Panther Fusion Sars-CoV-2 assay",1%
"Quest Diagnostic (17 March, Sars-Cov-2 rRt-PCR)",0%
"Abbott Molecular (18 March, RealTime Sars-CoV-2 assay)",-6%
